A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

Circio Holding ASA (OSE: CRNA), announces the presentation of new and strengthened in vivo data at the American Society of Gene and Cell Therapy (ASGCT) annual meeting 2025 in New Orleans, USA. In the ...

In recent years, circular RNA has emerged as the next generation RNA therapy due to its high protein expression efficiency, low immunogenicity, and manufacture stability. RXRG001 consists of the ...